Tele-rehabilitation in Chronic Respiratory Disease: an Observational Cohort Study

August 18, 2026 updated by: Roger Goldstein, West Park Healthcare Centre

Remote Exercise-based Pulmonary Rehabilitation Telemedicine in Chronic Respiratory Disease: an Observational Cohort Study

Pulmonary rehabilitation is a program that helps people with lung disease improve their function. It uses exercise, education, and self-management strategies to improve physical ability and quality of life. Because some people are unable to visit West Park Healthcare Centre, we established a remote supervised pulmonary rehabilitation program that patients can access via an electronic device (computer, tablet or smart phone). Regular quality assurance is necessary to ensure that the program is effective. We plan to collect and summarize the program's results. The benefit of doing so is that it allows us to make any changes or improvements that may help patients with chronic respiratory conditions.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Office Supervisor
  • Phone Number: 14162433631

Study Contact Backup

Study Locations

  • Canada
    • Ontario
      • Toronto, Ontario, Canada, M6M 2J5
        • Recruiting
        • West Park Healthcare Centre
        • Contact:
          • Research Assistant
          • Phone Number: 2186 14162433600
        • Contact:
          • Office Supervisor
          • Phone Number: 14162433631

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Adults diagnosed with chronic respiratory disease affecting the airways and other structures of the lungs causing dyspnea including chronic obstructive pulmonary disease (COPD), occupational lung diseases and pulmonary hypertension.

Description

Inclusion Criteria:

  • stable chronic respiratory disease
  • qualified candidates for pulmonary rehabilitation,
  • current non-smoker;
  • primary diagnosis chronic respiratory disease limited by dyspnea (mMRC≥2);
  • free of exacerbation at the time of admission, and
  • stable co-existing conditions

Exclusion Criteria:

  • completed PR within the previous 12 months of the current admission and
  • being unable to communicate with the treating team.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
health-related quality of life Chronic Respiratory Questionnaire - dyspnea
Time Frame: 12 weeks
Disease-specific health-related quality of life questionnaire. Developed to measure the impact of Chronic Obstructive Pulmonary Disease (COPD) on a person's life.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-minute walk test distance
Time Frame: 12 weeks
An objective evaluation of functional exercise capacity; the subject is asked to walk as far as possible for 6 minutes.
12 weeks
30-second Chair Stand Test
Time Frame: 12 weeks
A measurement to assess functional leg strength and endurance by involves recording the number of stands a person can complete in 30 seconds
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

West Park Healthcare Centre

Investigators

  • Principal Investigator: Roger Goldstein, MD, West Park Healthcare Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 6, 2023

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

April 30, 2028

Study Registration Dates

First Submitted

April 6, 2023

First Submitted That Met QC Criteria

April 6, 2023

First Posted (Actual)

April 20, 2023

Study Record Updates

Last Update Posted (Actual)

August 19, 2026

Last Update Submitted That Met QC Criteria

August 18, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PTR-RG2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe